Portfolio

Offering a platform technology for oral therapies that target specific tissues, leading to better outcomes through increased bioavailability and higher efficacy for unmet conditions.

Innovative platform to enable oral delivery of biologics for the treatment of chronic diseases. Novome Biotechnologies, develops engineered oral microbial therapies. The company’s novel delivery platform controls the colonization of therapeutically engineered bacteria, enabling first-in-class treatment of chronic disorders such as inflammatory bowel disease and enteric hyperoxaluria.

Through developing advanced Artificial Intelligence and Machine Learning solutions, Atomwise helps pharmaceutical industry overcome the challenges of drug discovery and create better medicines faster.

Replacing the Syringe with a Pill, i2O Therapeutics has developed a disruptive ionic liquid technology that enables oral delivery of biologics and other injection-based drugs. The ability to deliver injectable therapies orally has the potential to significantly improve patient adherence and outcomes.

Leading provider of personalized 3D printed chewable nutritional gummies with a clean ingredient profile, Remedy leverages its patented 3D-printing technology to produce gummy vitamin stacks that are enjoyable and convenient to take as a single oral dose.

Through its bio-simulation platform, VeriSIM Life enables the pharmaceutical industry to narrow down most efficacious compounds, de-risk R&D decisions, predict preclinical outcomes prior to human trials, reduce animal testing and therefore facilitating speed to market at a lower cost.

From small and large molecules to cell and gene therapy, solid oral dosages to injectables and beyond, Apprentice leverages artificial intelligence and augmented reality to get medicine to patients faster.